Regulatory approval of COVID-19 Vaccine AstraZeneca, MHRA (updated 23rd February 2021)

Information for healthcare professionals and the public about the COVID-19 Vaccine AstraZeneca. 23 February 2021 All documents were updated to include updated side effect frequency and efficacy data, including a new table on efficacy by dosing interval in the Information for UK Healthcare Professionals document. A new Annex (Annex 1: Addition of manufacturer and importer) was a dded to the Conditions of Authorisation document. 28 January 2021 Published new versions of the Conditions of Authorisation documents, with an additional clause relating to off-label prescribing
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news